Theravance Biopharma (TBPH) Capital Expenditures Growth (3y) (2016 - 2025)
Theravance Biopharma (TBPH) Capital Expenditures Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Theravance Biopharma |
839.69 Mn |
445.03 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-68.90% |
| Dec 31, 2024 |
-24.64% |
| Sep 30, 2024 |
-75.65% |
| Jun 30, 2024 |
-38.66% |
| Mar 31, 2024 |
-62.79% |
| Dec 31, 2023 |
-18.36% |
| Sep 30, 2023 |
-78.28% |
| Jun 30, 2023 |
-28.88% |
| Mar 31, 2023 |
-0.56% |
| Dec 31, 2022 |
-41.12% |
| Sep 30, 2022 |
-39.94% |
| Jun 30, 2022 |
-41.89% |
| Mar 31, 2022 |
-41.04% |
| Dec 31, 2021 |
-33.36% |
| Sep 30, 2021 |
-17.86% |
| Jun 30, 2021 |
-47.76% |
| Mar 31, 2021 |
-13.93% |
| Dec 31, 2020 |
69.60% |
| Sep 30, 2020 |
35.39% |
| Jun 30, 2020 |
47.49% |
